|
Name |
3,5-Dimethoxyphenol
|
Molecular Formula | C8H10O3 | |
IUPAC Name* |
3,5-dimethoxyphenol
|
|
SMILES |
COC1=CC(=CC(=C1)O)OC
|
|
InChI |
InChI=1S/C8H10O3/c1-10-7-3-6(9)4-8(5-7)11-2/h3-5,9H,1-2H3
|
|
InChIKey |
XQDNFAMOIPNVES-UHFFFAOYSA-N
|
|
Synonyms |
3,5-Dimethoxyphenol; 500-99-2; Phenol, 3,5-dimethoxy-; Taxicatigenin; Phloroglucinol dimethyl ether; 1-Hydroxy-3,5-dimethoxybenzene; 3,5-dimethoxy phenol; MFCD00008388; CHEBI:88715; 23UXW8136A; NSC-70955; UNII-23UXW8136A; EINECS 207-917-7; NSC 70955; Phenol,5-dimethoxy-; 3,5-dimethoxy-phenol; 3,5-Dimethoxyphenol, 99%; SCHEMBL233829; CHEMBL462989; DTXSID7075426; HMS1715K12; ZINC388212; NSC70955; STR06179; BBL101113; s6071; STL554909; AKOS000121581; AM83169; CS-W001117; HY-W001117; AC-11324; SY035504; DB-022082; FT-0614645; P0320; EN300-16614; F17066; A827974; W-105986; Q27160623; Z56347218; F0001-1304
|
|
CAS | 500-99-2 | |
PubChem CID | 10383 | |
ChEMBL ID | CHEMBL462989 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 154.16 | ALogp: | 1.6 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 38.7 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.707 |
Caco-2 Permeability: | -4.6 | MDCK Permeability: | 0.00001760 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.086 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.558 |
Blood-Brain-Barrier Penetration (BBB): | 0.132 | Plasma Protein Binding (PPB): | 83.68% |
Volume Distribution (VD): | 1.515 | Fu: | 13.26% |
CYP1A2-inhibitor: | 0.964 | CYP1A2-substrate: | 0.905 |
CYP2C19-inhibitor: | 0.421 | CYP2C19-substrate: | 0.801 |
CYP2C9-inhibitor: | 0.051 | CYP2C9-substrate: | 0.942 |
CYP2D6-inhibitor: | 0.711 | CYP2D6-substrate: | 0.925 |
CYP3A4-inhibitor: | 0.332 | CYP3A4-substrate: | 0.201 |
Clearance (CL): | 12.18 | Half-life (T1/2): | 0.867 |
hERG Blockers: | 0.035 | Human Hepatotoxicity (H-HT): | 0.171 |
Drug-inuced Liver Injury (DILI): | 0.088 | AMES Toxicity: | 0.022 |
Rat Oral Acute Toxicity: | 0.055 | Maximum Recommended Daily Dose: | 0.299 |
Skin Sensitization: | 0.916 | Carcinogencity: | 0.064 |
Eye Corrosion: | 0.947 | Eye Irritation: | 0.99 |
Respiratory Toxicity: | 0.378 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000736 | 0.667 | D09GYT | 0.346 | ||||
ENC000501 | 0.429 | D07EXH | 0.317 | ||||
ENC000671 | 0.426 | D02XJY | 0.295 | ||||
ENC000692 | 0.425 | D0B0AX | 0.279 | ||||
ENC000979 | 0.414 | D0E9CD | 0.277 | ||||
ENC005308 | 0.407 | D02UFG | 0.273 | ||||
ENC003894 | 0.407 | D0M8RC | 0.263 | ||||
ENC003430 | 0.397 | D0DJ1B | 0.262 | ||||
ENC004845 | 0.397 | D05CKR | 0.238 | ||||
ENC005746 | 0.396 | D06GCK | 0.238 |